Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04850313 · ClinicalTrials.gov registry record · NA
Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04850313 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 3 participants.
The verdict
NCT04850313, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The study design is a prospective, randomized, controlled interventional study to compare the outcome of ProKera Plus® with conventional treatment in patients with vision-threatening bacterial corneal ulcers. The study will be conducted at the University of Arkansas Medical Sciences (UAMS) in two phases for patients who present to an Ophthalmology clinic or Emergency Department at UAMS.
Interventions
- DEVICE ProProKera Plus®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04850313
The ClinicalTrials.gov registry entry for NCT04850313 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ProProKera Plus® is the first listed.
NCT04850313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04850313 about?
NCT04850313 is a clinical study titled "Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers". The study design is a prospective, randomized, controlled interventional study to compare the outcome of ProKera Plus® with conventional treatment in patients with vision-threatening bacterial corneal ulcers. The study will be conducted at the University of Arkansas Medical Sciences (UAMS) in two ph...
What is the current status of trial NCT04850313?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-11-09. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04850313?
The interventions under investigation include: ProProKera Plus® (DEVICE).
Who is sponsoring clinical trial NCT04850313?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.